Aulin Biotech's Staphylococcus aureus Vaccine Hits 73.25% Efficacy in Phase III
Start here
Aulin Biotech (688319.SH) has received the final report of the Phase III trial of its recombinant Staphylococcus aureus vaccine, expressed in E. coli, showing protective efficacy of 73.25% against S. aureus infection within 42 days after closed fracture surgery. The unblinding was completed in July 2026. The vaccine uses multi-target composite technology covering five antigen targets and showed good safety, with a favorable benefit-risk assessment supporting a marketing application. No similar product is marketed in China or abroad. A regulatory submission has not yet been made, and approval timing remains open.
Written by a model from the reports · updated 3 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- finance.sina.com.cnOlin Bio-tech's Recombinant Staphylococcus aureus Vaccine Shows Significant Protection in Phase III Report
Olin Bio-tech (688319.SH) has received the Phase III clinical study summary report for its recombinant Staphylococcus aureus vaccine (E. coli). The vaccine showed significant and stable protective efficacy in preventing S. aureus infection after orthopedic surgery, with good safety, and a favorable benefit-risk assessment supports a marketing application. Unblinding was completed in July 2026. The vaccine uses multi-target composite vaccine technology covering five antigen targets, and no similar product is marketed in China or abroad as of the disclosure date.
- finance.sina.com.cnPickAulin Biotech Recombinant Staphylococcus aureus Vaccine Shows 73.25% Protective Efficacy in Late-Stage Trial
Aulin Biotech (688319.SH) says the final report of the late-stage clinical study of its recombinant Staphylococcus aureus vaccine shows protective efficacy of 73.25% against S. aureus infection within 42 days after closed fracture surgery. The vaccine completed late-stage unblinding in July 2026, and the company recently received the final report.
Coverage and heat for this story
Reports so far 2·Heat now 6·Peak heat 10 (Oct 20 00:00)·Reports, 24h +2
Two panels, same clock (pointer stays in sync): top is cumulative editorial reports — only rises; last point = All reports; slope = new reports that hour. Bottom is Live-board heatIndex — 7-day participants with a 24-hour half-life, so it can fall when talk cools.